Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that a presentation of results from its Phase 3 clinical trial of Lymphoseek (technetium 99m tilmanocept) Injection in patients with head and neck squamous cell carcinoma received the 1st Investigator Award at the 2nd InternationaI Symposium on Thoracic and Upper Aerodigestive Malignancies.

15 Apr 2013

Study: Average-risk screening ADR is higher than current guidelines suggest for men and women

Researchers at Mayo Clinic in Jacksonville, Florida, report in a new study that average-risk screening adenoma detection rates (ADR) are significantly higher than current guidelines suggest for both men and women.

12 Apr 2013

Challenges in changing behaviors, factors to reduce cancer risk continue

An annual report from the American Cancer Society finds continuing challenges in changing behaviors and risk factors in order to reduce suffering and death from cancer.

12 Apr 2013

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

Research on a soy-based treatment for colorectal cancer, a promising agent in ovarian cancer, and a new drug target for advanced prostate cancer was presented at the American Association for Cancer Research 2013 Annual Meeting.

12 Apr 2013

Updated clinical data from phase I study of Ensituximab presented at AACR meeting

Precision Biologics announced today that in conjunction with researchers from Precsion Biologics , Johns Hopkins Medical Center and Duke University Medical Center presented updated clinical data from the phase I study of Ensituximab, a novel therapeutic antibody to treat pancreas and colorectal cancers

11 Apr 2013

Lynch syndrome and cancer risk: an interview with Prof. Ellen Kampman, Wageningen University

Lynch syndrome is one of the inherited cancer syndromes characterized by the development of colorectal cancer, endometrial cancer and other cancers at an early age.

10 Apr 2013

Combination of cetuximab and chemotherapy improves tumor shrinkage, extends survival

New results from a clinical trial conducted in Shanghai, China, indicate that adding cetuximab (Erbitux) to standard chemotherapy enables some patients with otherwise inoperable liver metastases due to colorectal cancer have their metastases surgically removed.

10 Apr 2013

Study evaluates efficacy of drug combinations in treating colorectal cancer

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Once colorectal cancer has spread to other parts of the body, only 11 percent of patients will survive five years from the date of their diagnosis.

8 Apr 2013

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).

8 Apr 2013

Penn Medicine study finds lower utilization of CTC for cancer screening

In 2009, the Centers for Medicare and Medicaid Services halted reimbursement for so-called "virtual colonoscopy" for routine colon-cancer screening in asymptomatic patients, in part due to concerns over how this procedure, computed tomography colonography, was being used in the elderly population.

5 Apr 2013

Men with Lynch syndrome face increased lifetime risk of prostate cancer

Men with an inherited genetic condition called Lynch syndrome face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center.

2 Apr 2013

Drug costs and pricing issues touch hospitals, independent pharmacies

NPR reports on how one hospital made what is termed an "unusual decision" -- it chose to not stock a new drug because it was very costly.

29 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

Colonoscopies are number one way to discover pre-cancerous growths, SLU gastroenterologist says

According to the American Cancer Society, our lifetime risk of developing colorectal cancer is about 1 in 20. This March, join Saint Louis University to share the message that prevention can stop colorectal cancer before it starts and help us change these odds.

25 Mar 2013

Special issue on colorectal cancer published in GIE: Gastrointestinal Endoscopy journal

In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer.

20 Mar 2013

AGA, CDC partner to promote free colonoscopies for uninsured patients

Colorectal cancer (CRC) is the second leading cause of cancer deaths among men and women nationwide. During National Colorectal Cancer Awareness Month, the Centers for Disease Control and Prevention (CDC) and the American Gastroenterological Association (AGA) are joining forces for the second year to promote free colonoscopies for uninsured patients.

19 Mar 2013

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

19 Mar 2013

AMGA Distinguished Corporate Partner Award to be presented to Exact Sciences

The American Medical Group Association announced today that it will present the AMGA Distinguished Corporate Partner Award on March 15 to Exact Sciences at its 2012 Annual Conference, March 14-16 at the Hilton Bonnet Creek Resort in Orlando.

16 Mar 2013

Results from GTx's Phase 2 clinical trial of enobosarm published online

GTx, Inc. today announced that the journal, The Lancet Oncology, has published online ahead of its April print edition the results from GTx's randomized, double-blind, placebo-controlled Phase 2 clinical trial of enobosarm to assess its effects on muscle wasting and physical function in patients with cancer.

15 Mar 2013

Maintaining high-quality CT colonography while reducing radiation dose is possible, finds study

A new study by a Rhode Island Hospital researcher has found it's possible to maintain high-quality CT colonography diagnostic images while reducing the radiation dose.

13 Mar 2013

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

Study: Average-risk screening ADR is higher than current guidelines suggest for men and women

Challenges in changing behaviors, factors to reduce cancer risk continue

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

Updated clinical data from phase I study of Ensituximab presented at AACR meeting

Lynch syndrome and cancer risk: an interview with Prof. Ellen Kampman, Wageningen University

Combination of cetuximab and chemotherapy improves tumor shrinkage, extends survival

Study evaluates efficacy of drug combinations in treating colorectal cancer

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Penn Medicine study finds lower utilization of CTC for cancer screening

Men with Lynch syndrome face increased lifetime risk of prostate cancer

Drug costs and pricing issues touch hospitals, independent pharmacies

First Edition: March 28, 2013

Colonoscopies are number one way to discover pre-cancerous growths, SLU gastroenterologist says

Special issue on colorectal cancer published in GIE: Gastrointestinal Endoscopy journal

AGA, CDC partner to promote free colonoscopies for uninsured patients

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

AMGA Distinguished Corporate Partner Award to be presented to Exact Sciences

Results from GTx's Phase 2 clinical trial of enobosarm published online

Maintaining high-quality CT colonography while reducing radiation dose is possible, finds study

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in